Success Stories: Advancing Liver Disease Research: NIW Approved for Clinical Medicine Expert

Posted by wegreened on September 29, 2025 in NIW, General Medicine (Public Health, Clinical Research, Infectious Diseases, Vaccines, Virology, Epidemiology, Clinical Psychology, Psychiatry)

On March 26^th, 2025, we received another EB-2 NIW (National Interest Waiver) approval for an Internal Medicine Chief Resident in the Field of Clinical Medicine (Approval Notice).

General Field: Clinical Medicine

Position at the Time of Case Filing: Internal Medicine Chief Resident

Country of Origin: India

State of Residence at the Time of Filing: Iowa

Approval Notice Date: March 26^th, 2025

Processing Time: 10 months, 20 days (Premium Processing Requested)

Case Summary:

A dedicated expert in clinical medicine from India has earned EB-2 NIW (National Interest Waiver) approval for his impactful research into gastrointestinal and liver diseases. His work focuses on improving how these widespread conditions are diagnosed, managed, and treated, particularly through behavioral and therapeutic strategies that address not only the disease but also the chronic pain often associated with it.

This researcher’s approach to clinical innovation is vital in alleviating the global burden of liver-related diseases. By developing targeted strategies for diagnosis and therapy, his work contributes directly to reducing the cost and complexity of care. In doing so, he is helping to shape more effective and sustainable healthcare solutions for patients suffering from long-term hepatic conditions. His research is not only advancing scientific understanding but also directly influencing improved clinical outcomes.

To support his NIW petition, the North America Immigration Law Group (NAILG) meticulously documented his qualifications, research impact, and professional recognition. The petition highlighted his 7 peer-reviewed journal articles (4 of them first-authored) and 1 accepted publication, as well as 33 citations tracked on Google Scholar. His contribution to the scientific community was further evidenced by his service as a peer reviewer for at least 18 scholarly evaluations, demonstrating his respected role among peers in the field.

A compelling expert testimonial submitted as part of the case captured the significance of his work:

“[Client] continues to conduct cutting-edge research into the etiology of liver diseases and novel therapies to treat them. The high quality of his research is clearly shown by his esteemed professional background and the valuable insights he has delivered to physicians. [Client]'s research in the clinical medicine field is undoubtedly of benefit to both U.S. and global research communities.”

This approval stands as a testament not only to the researcher’s dedication and scientific value but also to the strength of NAILG’s case-building strategy. We are proud to have supported this important petition and look forward to the ongoing contributions he will make in improving patient care and advancing clinical medicine.

--------------------------------------------

North America Immigration Law Group (Chen Immigration Law Associates) is a U.S. immigration law firm dedicated to representing corporations, research institutions, and individuals from all 50 U.S. states regarding I-140 immigration petitions. We specialize in employment-based immigration petition and have a proven record of high success rate for the categories of: EB2-NIW (National Interest Waiver), EB1-A (Alien of Extraordinary Ability), EB1-B (Outstanding Researcher/Professor) and O-1 (Alien of Extraordinary Ability).

Our Sixty-four Thousand I-140 Approvals Provide Unprecedented Insight into the USCIS Adjudication Trend

With nearly 64,000 EB-1A, EB-1B, EB-2 NIW and O-1 cases approved, we have first hand information on the manner in which the USCIS adjudicate I-140 cases. As the USCIS has constantly changed its adjudication standards for the EB-1A, EB-1B and EB-2 NIW categories, our firm's huge database of successful cases gives you unprecedented insight to USCIS adjudication trends. We carefully analyze the data for all of our cases and apply the results of our analyses toward giving our clients up-to-date advice and adapting our strategies such that we remain on par with the ever-shifting landscape of immigration law in the U.S. With us, you will always have access to important updates, strategies, and information so that you can make the most informed decisions about your case.

We Have Helped Tens of Thousands of Clients with Credentials and Backgrounds Similar to Yours

With our exceedingly large number of successful petitions, no matter what credentials you have, no matter your background and field of expertise, no matter your visa status or nationality, chances are we have helped hundreds or even thousands of clients just like you. Our clients are usually impressed with how well we understand their research and work. Our insight and understanding stems from the fact that we have handled many cases with elements similar to yours already, and this helps us devise the best strategies for each individual petition.

Vast Majority of Clients Came to Us Because of Referrals

For years, our firm has attracted new clients based solely on word of mouth, recommendations, and the positive collaboration experiences shared with them by their friends and family. We take pride in our reputation and work hard to ensure that we provide a green card application experience that our clients are happy to share with their friends and colleagues. That is how our cumulative total of approved cases grew from 600 in 2013 to nearly 64,000 in 2025.

Track Record of Success EB-1 and NIW Approvals

(2012.01 - 2025.12)

Category	Approval or Refund^®		Approval or Refiling^TM
	Approval or Refund^®
Category	Approved Sum	Success Rate	Approved Sum	Success Rate
NIW	42,047	99%	5,258	97%
EB1A	9,218	91%	4,534	86%
EB1B	1,488	98%	448	93%
Total	52,753	98%	10,240	92%